Mexico Pharmaceuticals Report - August 2025

Na minha lista:
Detalhes bibliográficos
Publicado no:Fitch Solutions Country Industry Reports (Aug 8, 2025), p. 1-57
Publicado em:
Fitch Solutions Group Limited
Assuntos:
Acesso em linha:Citation/Abstract
Full Text - PDF
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

MARC

LEADER 00000nab a2200000uu 4500
001 3237589702
003 UK-CbPIL
022 |a 2976-4750 
035 |a 3237589702 
045 0 |b d20250808 
245 1 |a Mexico Pharmaceuticals Report - August 2025 
260 |b Fitch Solutions Group Limited  |c Aug 8, 2025 
513 |a Industry Report 
520 3 |a Despite ongoing challenges in drug procurement and patent enforcement, Mexico’s pharmaceutical industry is set for continued growth, driven by rising demand for advanced treatments for chronic diseases. As the second-largest pharmaceutical market in Latin America, Mexico presents substantial opportunities for companies focused on innovative medicines. However, comparatively low per capita pharmaceutical spending may constrain the broader uptake of patented drugs, potentially increasing the market share of generics. Government efforts to strengthen local drug manufacturing are anticipated to encourage greater international collaboration, particularly in the field of technology transfer. 
651 4 |a Mexico 
653 |a Pharmaceuticals 
653 |a Statistical data 
653 |a Industrywide conditions 
653 |a Market analysis 
653 |a Industry analysis 
653 |a Business forecasts 
653 |a SWOT analysis 
653 |a Pharmaceutical industry 
773 0 |t Fitch Solutions Country Industry Reports  |g (Aug 8, 2025), p. 1-57 
786 0 |d ProQuest  |t ABI/INFORM Trade & Industry 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3237589702/abstract/embedded/6A8EOT78XXH2IG52?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3237589702/fulltextPDF/embedded/6A8EOT78XXH2IG52?source=fedsrch